Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
LDOS | C | Leidos Holdings, Inc. | 0.50 | |
DCTH | C | Delcath Systems, Inc. | -0.91 | |
NBIX | C | Neurocrine Biosciences, Inc. | 0.52 | |
VNDA | C | Vanda Pharmaceuticals Inc. | 3.04 | |
PULM | C | Pulmatrix, Inc. | 0.16 | |
MNOV | B | MediciNova, Inc. | 6.50 | |
IFRX | B | InflaRx N.V. | 0.97 | |
KRYS | B | Krystal Biotech, Inc. | 4.45 | |
GH | B | Guardant Health, Inc. | 5.39 | |
AUPH | B | Aurinia Pharmaceuticals Inc | 1.03 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
HELX | D | Franklin Genomic Advancements ETF | 5.67 | |
BBP | C | BioShares Biotechnology Products Fund | 5.15 | |
SHLD | C | Global X Defense Tech ETF | 4.86 | |
HACK | B | ETFMG Prime Cyber Security ETF | 4.51 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 4.37 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles